Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical Breast Cancer|April 3, 2020
Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast CancerBenjamin M Parsons, David R Meier, Craig S Richmond, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2Kate S Ashton, David J St Jean, Steve F Poon, et al.
The Journal of Biological Chemistry|May 20, 1994
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulinM X Sliwkowski, G Schaefer, R W Akita, et al.
The New Phytologist|November 22, 2017
Fusarium graminearum: pathogen or endophyte of North American grasses?Lotus A Lofgren, Nicholas R LeBlanc, Amanda K Certano, et al.
Msphere|December 8, 2021
Host Lung Environment Limits Aspergillus fumigatus Germination through an SskA-Dependent Signaling ResponseMarina E Kirkland, McKenzie Stannard, Caitlin H Kowalski, et al.
Cancer Research|August 10, 2013
Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progressionTarah M Regan Anderson, Danielle L Peacock, Andrea R Daniel, et al.
Cancer Cell|September 3, 2002
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growthDavid B Agus, Robert W Akita, William D Fox, et al.
The Journal of Nursing Administration|September 30, 2016
Advanced Practice Providers' Perceptions of Patient Workload: Results of a Multi-Institutional SurveyApril N Kapu, Carmel A McComiskey, Lacey Buckler, et al.
Pageof 7